Abstract:Purpose/Objective(s) RECQL4 was considered a susceptible target for cancer therapy by playing diverse roles in the maintenance of genomic stability. Understanding more about the molecular characteristics of RECQL4 enables the better selection of HCC patients who would derive benefit from radiation therapy (RT) combined with immune checkpoint immunotherapies (ICIs). Materials/Methods We collected RNA sequencing data of 1175 HCC and 767 adjacent non-tumor tissues from 5 cohorts, followed by comprehensive evaluation of the expression patterns and multi-omics characteristics of RECQL4. Then, the expression of RECQL4 was systematically associated with HCC genomic instability and tumor microenvironment (TME) with multi-omics data and multicolor immunofluorescence staining. cGAS−/− and STING−/- mice were used to determine the relation of RECQL4 and cGAS-STING signaling pathway in HCC in vivo. Finally, clinical and pathologic data were collected retrospectively on HCC patients at the Zhongshan Hospital of Fudan University and associations with survival were determined. Results We found that RECQL4 was specifically overexpressed in HCC and significantly associated with a poor prognosis. The CNV results showed RECQL4 mutations was mainly caused by 8q24 and the expression was positive correlation with CNV burden. Moreover, RECQL4 expression was significantly and negatively correlated with the infiltrating levels of dendritic cells (DCs) and CD8 + T cells, which means high RECQL4 designed a non-inflamed TME. Low RECQL4 induces DCs maturation and antigen presentation by triggering the cGAS-STING pathway, and further activates CD8 + T cell-mediated the adaptive immunity. The result was further confirmed in RT combined with ICIs of HCC, which suggests that low RECQL4 bridges the DNA damaging capacity of RT with the CD8+ cytotoxic T cell-mediated destruction of cancer through innate immune signaling cGAS–STING to make the combined therapy better efficacy. Retrospective analysis also showed that HCC patients with low RECQL4 expression were more sensitive to RT with ICIs. Conclusion RECQL4 mediates a non-inflamed TME by regulating the cGAS-STING pathway on immune cells in HCC. HCC patients with low RECQL4 could derive response and benefit from several treatment options. RECQL4 serves as a new target for HCC radiotherapy combined with immunotherapy.

Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway

Distinct prognosis of mRNA expression of the five RecQ DNA-helicase family members - RECQL , BLM , WRN , RECQL4 , and RECQL5 - in patients with breast cancer.

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

Germline RECQL Gene Mutations in Chinese Patients with Breast Cancer

Comprehensive Profiling of Circrnas and the Tumor Suppressor Function of Circhipk3 in Clear Cell Renal Carcinoma

Downregulation of RECQL 4 inhibits gastric cancer cell proliferation and induces cell cycle arrest at G 0 / G 1 phase

RecQ protein‐like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2

RECQL1 Plays an Important Role in the Development of Tongue Squamous Cell Carcinoma

RECQL4 Remodels the Tumor Immune Microenvironment Via the Cgas-Sting Pathway in Hepatocellular Carcinoma

RECQL4 Inhibits Radiation‐Induced Tumor Immune Awakening Via Suppressing the Cgas‐sting Pathway in Hepatocellular Carcinoma

RECQL4 Regulates DNA Damage Response and Redox Homeostasis in Esophageal Cancer

HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing P53 Expression Via Co-Repressor NCOR1

The Interaction Between PDCD4 and YB1 is Critical for Cervical Cancer Stemness and Cisplatin Resistance.

Abstract A18: Predictive and prognostic significance of RECQ1 expression in breast cancer

RECQL4, Negatively Regulated by miR-10a-5p, Facilitates Cell Proliferation and Invasion via MAFB in Ovarian Cancer

Human Recql4 Helicase Plays Critical Roles in Prostate Carcinogenesis

Mining the Role of RECQL5 in Gastric Cancer and Seeking Potential Regulatory Network by Bioinformatics Analysis

Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer

Overexpression of RECQL4 is Associated with Poor Prognosis in Patients with Gastric Cancer.

Low Expression of RECQL is Associated with Poor Prognosis in Chinese Breast Cancer Patients

Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy